Global Markets on Infectious Diseases

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

  • Mechanism of action of virus
  • Prevention and control of virus
  • Rabies
  • Malaria, Dengue fever, River blindness
  • Available vaccines

Related Conference of Global Markets on Infectious Diseases

September 30-30, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
September 30-30, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
November 04-05, 2021

9th World Summit on Immunology & Immunotherapy

Prague, Czech Republic
November 08-09, 2021

International Conference on Immunology Research

Las Vegas, USA
December 23-23, 2021

13th Annual Conference on Clinical Immunology

Cape Town, South Africa
February 07-08, 2022

International Conference on Vaccine Research

Paris, France
March 21-22, 2022

37th International Conference on Immunology

Brussels, Aland Islands
March 21-22, 2022

15th Global Summit on Immunology and Cell Biology

Tokyo, Japan
May 02-03, 2022

16th International Conference on European Immunology

Zurich, Switzerland

Global Markets on Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in